Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA

PURPOSE: Although adjuvant systemic therapy (AST) helps increase breast cancer-specific survival (BCSS), there is a growing concern for overtreatment. By estimating the expected BCSS of AST using PREDICT, this study aims to quantify the number of patients treated with AST without benefit to provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragusi, M. A. A., van der Velden, B. H. M., van Maaren, M. C., van der Wall, E., van Gils, C. H., Pijnappel, R. M., Gilhuijs, K. G. A., Elias, S. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993748/
https://www.ncbi.nlm.nih.gov/pubmed/35239071
http://dx.doi.org/10.1007/s10549-022-06550-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993748/
https://www.ncbi.nlm.nih.gov/pubmed/35239071
http://dx.doi.org/10.1007/s10549-022-06550-2

Ejemplares similares